This repo describes analysis performed in the publication titled "Combined disruption of T cell inflammatory regulators Regnase-1 and Roquin-1 enhances antitumor activity of engineered human T cells".
Sample type: primary human T cells
Number of bio samples: 3
- sample 1: mesothelin-targeting CAR-T cells, donor ID # 539, 1 technical replicate
- sample 2: mesothelin-targeting CAR-T cells, donor ID # 561, 2 technical replicates
- sample 3: NY-ESO-1-targeting TCR-T cells, donor ID # 579, 2 technical replicates
Number of experimental groups per sample: 4
- Regnase-1 knockout (Reg1-KO)
- Roquin-1 knockout (Roq1-KO)
- Regnase-1 and Roquin-1 double knockout (DKO)
- No knockout (Mock)
Total samples = 20 (sample 1 * 4 groups * 1 rep + sample 2 * 4 groups * 2 reps + sample 3 * 4 groups * 2 reps)
See Reg1_Roq1_knockout_analysis.Rmd for main analysis code and generation of data files and plots.
See XXX for processing code from raw data to input data into main analysis.